Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Coronavirus Update - Our team is available
In view of the spread of Covid-19 (coronavirus) in our country and across the world, our topmost priority is the health and safety of all our customers and employees. Our team will be available and the best way to reach us at this time is via email: firstname.lastname@example.org
BIO International Convention
Novosanis will be present at the BIO International Convention as part of the Belgian delegate via Flanders Investment and Trade. The congress takes place in San Diego, from 8 to 11 June. Our CEO (Vanessa Vankerckhoven) and our CTO (Koen Beyers) can be found at the Belgian Pavilion and look forward...